title: Actual developments in European regulatory and health technology assessment of new cancer drugs: what does this mean for oncology in Europe?
authors: Medical Clinic II, University Hospital, Frankfurt.
authors: L
authors: L
authors: Bergmann
authors: H
authors: H
authors: Enzmann
authors: K
authors: K
authors: Broich
authors: A
authors: A
authors: Hebborn
authors: S
authors: S
authors: Marsoni
authors: L
authors: L
authors: Goh
authors: J F
authors: JF
authors: Smyth
authors: H
authors: H
authors: Zwierzina
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use*; D004354:Drug Screening Assays, Antitumor; D005060:Europe; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D013673:Technology Assessment, Biomedical
chemical_list: D000970:Antineoplastic Agents